Page last updated: 2024-08-25

rosiglitazone and Brain Emboli

rosiglitazone has been researched along with Brain Emboli in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Allahtavakoli, M; Pourshanazari, A; Roohbakhsh, A; Shabanzadeh, A	1

Other Studies

1 other study(ies) available for rosiglitazone and Brain Emboli

Article	Year
Combination therapy of rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, and NMDA receptor antagonist (MK-801) on experimental embolic stroke in rats. Basic & clinical pharmacology & toxicology, 2007, Volume: 101, Issue:5 Topics: Animals; Behavior, Animal; Blood Coagulation; Brain; Cerebral Infarction; Dimethyl Sulfoxide; Dizocilpine Maleate; Drug Synergism; Drug Therapy, Combination; Hypnotics and Sedatives; Intracranial Embolism; Neuroprotective Agents; PPAR gamma; Rats; Receptors, N-Methyl-D-Aspartate; Rosiglitazone; Stroke; Thiazolidinediones	2007

Article

Year

Combination therapy of rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, and NMDA receptor antagonist (MK-801) on experimental embolic stroke in rats.

Basic & clinical pharmacology & toxicology, 2007, Volume: 101, Issue:5

Topics: Animals; Behavior, Animal; Blood Coagulation; Brain; Cerebral Infarction; Dimethyl Sulfoxide; Dizocilpine Maleate; Drug Synergism; Drug Therapy, Combination; Hypnotics and Sedatives; Intracranial Embolism; Neuroprotective Agents; PPAR gamma; Rats; Receptors, N-Methyl-D-Aspartate; Rosiglitazone; Stroke; Thiazolidinediones

2007